Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.

Keefe, Richard S E

Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. [electronic resource] - Archives of general psychiatry Jun 2007 - 633-47 p. digital

Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

0003-990X

10.1001/archpsyc.64.6.633 doi


Adult
Antipsychotic Agents--therapeutic use
Benzodiazepines--therapeutic use
Cognition Disorders--diagnosis
Cohort Studies
Dibenzothiazepines--therapeutic use
Double-Blind Method
Female
Humans
Male
Neuropsychological Tests--statistics & numerical data
Olanzapine
Perphenazine--therapeutic use
Piperazines--therapeutic use
Quetiapine Fumarate
Risperidone--therapeutic use
Schizophrenia--diagnosis
Schizophrenic Psychology
Thiazoles--therapeutic use
Treatment Outcome